Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genotype and methylome study of celiac disease and control individuals

ABSTRACT: Genotype and methylome study of celiac disease and control individuals

PROVIDER: PRJNA330986 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Genotype study of celiac disease and control individuals

Project description:This collection of samples were genotyped to use altogether with other data to gain insight into the mechanism behind celiac disease.

2019-02-04 | GSE84739 | GEO

Genotype and methylome study of celiac disease and control individuals

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-02-04 | GSE84745 | GEO

Methylome landscape of epithelial and immune fractions of celiac disease

Project description:These samples were analyzed to gain insight into the mechanisms behind celiac disease, analyzing their methylome.

2019-02-04 | GSE84743 | GEO

Transcription profiling of MIII celiac disease patients vs controls (M0) individuals

Project description:Comparison of MIII celiac disease patients to controls (M0) individuals.

2005-01-01 | E-MEXP-42 | biostudies-arrayexpress

Gut microbiome of individuals with Non-celiac gluten wheat sensitivity

Project description:Gut microbiome of individuals with Non-celiac gluten wheat sensitivity Raw sequence reads

| PRJNA1183595 | ENA

Leukocytes methylome of individuals from leprosy endemic area

Project description:Leukocytes methylome of individuals from leprosy endemic area

| PRJNA809762 | ENA

Therapeutic TG2 Inhibition Reverses Systemic Multiomic Dysregulation in Celiac Disease

Project description:Background and Aims: Celiac disease (CeD) is an autoimmune disease triggered by dietary gluten in genetically predisposed individuals. Deamidation of gluten peptides by the CeD autoantigen and enzyme transglutaminase 2 (TG2) is central to the pathogenesis of CeD. Inhibition of TG2 with the specific inhibitor ZED1227 effectively prevents gluten-induced histological damage in CeD patients. Here we aimed to explore the blood DNA methylomic changes in ZED1227-treated CeD patients undergoing a gluten challenge. Results: Drug treatment revealed consistent patterns suggesting normalization of the DNA methylome indicating that ZED1227 attenuated the systemic responses to gluten challenge. Conclusions: These findings provide evidence that ZED1227 can significantly prevent the gluten-induced CeD-associated systemic changes. Clinical trial: EudraCT 2017-002241-30

2026-06-18 | GSE319777 | GEO

Primary human leucocyte RNA expression of unrelated celiac disease cases and unrelated healthy controls.

Project description:The goal of this study was to study the effect of genetic variation on gene expression of untouched primary leucocytes. This expression data is used in conjunction with genome-wide association genotype data that is available for the celiac disease samples, typed on the Illumina Infinium HumanHap300 platform. All genotype data are available upon request.

2008-10-01 | GSE11501 | GEO

Expression analysis in intestinal mucosa of genes under association peaks in celiac disease

Project description:Celiac disease is a chronic immune-mediated disorder with an important genetic component. To date, there are 57 independent association signals from 39 non-HLA loci, and a total of 66 candidate genes have been proposed. We aimed to scrutinize the functional implication of 45 of those genes by analyzing their expression in the disease tissue of celiac patients (at diagnosis/treatment) compared to non-celiac controls. The sample set consisted of 15 CD children at diagnosis (on a gluten-containing diet, with CD associated antibodies, atrophy of intestinal villi and crypt hyperplasia), and the same patients in remission after being treated with GFD for >2 years (asymptomatic, antibody negative, and normalized intestinal epithelium at that time), plus 15 tissue samples from non-celiac individuals not suffering from inflammation at the time of endoscopy used as controls

2014-09-30 | E-GEOD-61849 | biostudies-arrayexpress

16S V3-V4 -based microbial profiling of duodenal mucosa samples obtained by esophagogastroduodenoscopy from patients affected by potential celiac disease and celiac disease

Project description:Potential celiac diseasase (PCD) is characterized by a positive celiac disease (CD) serology and a normal small intestinal mucosa. This particular condition is usually considered a clinical challenge because, although its diagnostic criteria are clear, many questions are still unsettled. Therefore, given that PCD is a valuable biological model of the pathway leading to small intestinal mucosal damage in genetically predisposed individuals, the aim of our study is to evaluate whether immunological, microbial and lipid signatures could better characterize the PCD from the CD condition.

2022-10-19 | GSE181070 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data